1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one

C24H35N5O — CID 110069774

IUPAC1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one
SMILESCC(C)N1[C@H]2CCNc3ccccc3CN(C(=O)CCCn3cccn3)C[C@@H]1CC2
InChIInChI=1S/C24H35N5O/c1-19(2)29-21-10-11-22(29)18-27(24(30)9-5-15-28-16-6-13-26-28)17-20-7-3-4-8-23(20)25-14-12-21/h3-4,6-8,13,16,19,21-22,25H,5,9-12,14-15,17-18H2,1-2H3/t21-,22+/m1/s1
InChIKeyMQOSEBUTEPLPNB-YADHBBJMSA-N
MW409.58 g/mol
LogP3.75
Rot. Bonds5

About 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one

1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one (PubChem CID 110069774) has the molecular formula C24H35N5O and a molecular weight of 409.58 g/mol. Its IUPAC name is 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one.

Molecular Properties

Compound Name1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one
PubChem CID110069774
Molecular FormulaC24H35N5O
Molecular Weight409.58 g/mol
Exact Mass409.28
IUPAC Name1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one
SMILESCC(C)N1[C@H]2CCNc3ccccc3CN(C(=O)CCCn3cccn3)C[C@@H]1CC2
InChIInChI=1S/C24H35N5O/c1-19(2)29-21-10-11-22(29)18-27(24(30)9-5-15-28-16-6-13-26-28)17-20-7-3-4-8-23(20)25-14-12-21/h3-4,6-8,13,16,19,21-22,25H,5,9-12,14-15,17-18H2,1-2H3/t21-,22+/m1/s1
InChIKeyMQOSEBUTEPLPNB-YADHBBJMSA-N
XLogP3.75
TPSA53.40 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500409.58
LogP ≤ 53.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one?
The IUPAC name of 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one (CID 110069774) is 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one.
What is the SMILES notation for 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one?
The canonical SMILES for 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one is CC(C)N1[C@H]2CCNc3ccccc3CN(C(=O)CCCn3cccn3)C[C@@H]1CC2.
What is the InChIKey of 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one?
The InChIKey is MQOSEBUTEPLPNB-YADHBBJMSA-N. The full InChI is InChI=1S/C24H35N5O/c1-19(2)29-21-10-11-22(29)18-27(24(30)9-5-15-28-16-6-13-26-28)17-20-7-3-4-8-23(20)25-14-12-21/h3-4,6-8,13,16,19,21-22,25H,5,9-12,14-15,17-18H2,1-2H3/t21-,22+/m1/s1.
What are the key properties of 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one?
1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one has a molecular weight of 409.58 g/mol, XLogP of 3.75, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(1S,14R)-17-propan-2-yl-3,11,17-triazatricyclo[12.2.1.05,10]heptadeca-5,7,9-trien-3-yl]-4-pyrazol-1-ylbutan-1-one is sourced from PubChem (CID 110069774), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).